Testing effectiveness (Phase 2)Study completedNCT00077675
What this trial is testing
Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
Who this might be right for
Infections, Gram-positive Bacterial
Cumberland Pharmaceuticals 201